Fig. 1.

Disease-free, metastases-free and breast cancer-specific survival for patients according to schedule of chemotherapy. Kaplan–Meier cumulative survival curves for a disease-free survival and b metastases-free survival for patients who received adjuvant chemotherapy (CT) (n = 168), neoadjuvant CT (n = 93) or no CT (n = 55) (log-rank test DFS, p value = 0.024) and (log-rank test MFS, p value = 0.045). c Kaplan–Meier cumulative survival curves for breast cancer-specific survival for patients for patients who received adjuvant therapy (n = 161), neoadjuvant CT (n = 96) or no CT (n = 64) (log-rank test, p value < 0.001)